SEC Tracker
Get the app

Cerus CERS

Cerus Q3 FY24: net loss $2.9M; diluted EPS −$0.02

Form
10-Q
Filed
Period
Importance
Notable
Document
10-Q

Key figures from this report

These are the numbers Cerus reported for Q3 FY24, the quarter ended Sep 30, 2024, as tagged in the filing’s XBRL data, each against the same quarter a year earlier. A plain-English reading of this report is not written yet.

  1. Net income−$2.9MNo year-earlier figure tagged10-Q income statement, on EDGAR
  2. Diluted EPS−$0.02No year-earlier figure tagged10-Q income statement, on EDGAR
  3. Cash and cash equivalents$21.6MNo year-earlier figure taggedCash and equivalents only; the company page adds short-term investments.10-Q balance sheet, on EDGAR
  4. Cash from operations$4.1MNo year-earlier figure tagged10-Q cash flow statement, on EDGAR; the filing reports year-to-date cash flows; this quarter is the year-to-date total less the earlier quarters

Every quarter in the financial tables

View on EDGAR

Open in the app

Get an email when Cerus files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 3841 and related industry codes: the same peer list as the financial tables.

  1. SANUWAVE Health SNWV public float $233M, Jun 30, 2025
  2. Electromed ELMD public float $224M, Dec 31, 2025
  3. Tactile Systems Technology TCMD public float $223M, Jun 30, 2025
  4. Orasure Technologies OSUR public float $218M, Jun 30, 2025
  5. Heartflow HTFL